A recent study of human cancer cell lines showed that ZSTK474 has potent effects on arrest of cell cycle progression through inhibition of phosphorylation or expression of Akt and/or mTORC1 substrates, such as p-GSK3β, p-mTOR, p-p70S6K and cyclin D1. The gene discussed is MTOR; the disease is cancer.